LABD vs. XDSQ
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and XDSQ (Innovator US Equity Accelerated ETF) are both Leveraged Equities funds. LABD is passively managed, while XDSQ is actively managed. Over the past 5 years, LABD returned -41.45%/yr vs 9.80%/yr for XDSQ. At a correlation of -0.54, they often move in opposite directions. LABD charges 1.06%/yr vs 0.79%/yr for XDSQ.
Performance
LABD vs. XDSQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -29.83% return, which is significantly lower than XDSQ's 2.80% return.
LABD
- 1D
- -4.73%
- 1M
- 4.70%
- YTD
- -29.83%
- 6M
- -31.22%
- 1Y
- -80.27%
- 3Y*
- -49.85%
- 5Y*
- -41.45%
- 10Y*
- -56.11%
XDSQ
- 1D
- 0.01%
- 1M
- 1.59%
- YTD
- 2.80%
- 6M
- 3.86%
- 1Y
- 15.98%
- 3Y*
- 15.02%
- 5Y*
- 9.80%
- 10Y*
- —
LABD vs. XDSQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -29.83% | -70.07% | -21.43% | -41.77% | -32.68% | 21.59% |
XDSQ Innovator US Equity Accelerated ETF | 2.80% | 14.22% | 23.12% | 23.00% | -16.78% | 12.75% |
Correlation
The correlation between LABD and XDSQ is -0.47, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.51 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.55 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 2021 | -0.54 |
The correlation between LABD and XDSQ has been stable across timeframes, ranging from -0.55 to -0.47 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. XDSQ — Risk / Return Rank
LABD
XDSQ
LABD vs. XDSQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Innovator US Equity Accelerated ETF (XDSQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | XDSQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.58 | ||
| Sortino ratioReturn per unit of downside risk | -4.32 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.32 | -0.57 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 1.67 | -2.64 |
| Martin ratioReturn relative to average drawdown | -1.31 | 7.97 | -9.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABD | XDSQ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.06 | 1.52 | -2.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | 0.65 | -1.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.59 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | 0.69 | -1.24 |
Drawdowns
LABD vs. XDSQ - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than XDSQ's maximum drawdown of -26.06%. Use the drawdown chart below to compare losses from any high point for LABD and XDSQ.
Loading charts...
Drawdown Indicators
| LABD | XDSQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -26.06% | -73.93% |
Max Drawdown (1Y)Largest decline over 1 year | -83.21% | -9.60% | -73.61% |
Max Drawdown (3Y)Largest decline over 3 years | -95.31% | -19.15% | -76.16% |
Max Drawdown (5Y)Largest decline over 5 years | -98.24% | -26.06% | -72.18% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | — | — |
Current DrawdownCurrent decline from peak | -99.99% | 0.00% | -99.99% |
Average DrawdownAverage peak-to-trough decline | -90.92% | -4.96% | -85.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.36% | 2.01% | +59.35% |
Volatility
LABD vs. XDSQ - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 27.46% compared to Innovator US Equity Accelerated ETF (XDSQ) at 0.57%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than XDSQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | XDSQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.46% | 0.57% | +26.89% |
Volatility (6M)Calculated over the trailing 6-month period | 61.67% | 8.40% | +53.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.77% | 10.56% | +65.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.26% | 15.27% | +80.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.93% | 15.10% | +80.83% |
LABD vs. XDSQ - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than XDSQ's 0.79% expense ratio.
Dividends
LABD vs. XDSQ - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 6.45%, while XDSQ has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 6.45% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% |
XDSQ Innovator US Equity Accelerated ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
LABD and XDSQ have a correlation of -0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (27.46%) compared to XDSQ (0.57%). In terms of maximum drawdown, LABD dropped -99.99% vs XDSQ's -26.06%.
On 5-year performance, XDSQ leads with 9.80% vs -41.45% for LABD. On fees, XDSQ is cheaper at 0.79% per year. On volatility, XDSQ has been the lower-risk option at 0.57%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, XDSQ has performed better with a 9.80% return vs -41.45%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XDSQ is cheaper with a 0.79% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 6.45%, compared with 0.00% for XDSQ.
They also come from different issuers: Direxion and Innovator. Their fees differ too: 1.06% for LABD and 0.79% for XDSQ.
XDSQ currently has the higher Sharpe Ratio (1.52 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and XDSQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer